Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments

European Cardiology Review - United Kingdom
doi 10.15420/ecr.2018.34.2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Radcliffe Group Ltd

Related search

Effects of Sodium Glucose Cotransporter Type 2 Inhibitors on Heart Failure

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Heart Failure Prevention With Sodium‐glucose Cotransporter 2 Inhibitors

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Cardiovascular Effects of Sodium Glucose Cotransporter 2 Inhibitors

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2018English

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors

Journal of Clinical Medicine Research
2017English

Inhibition of Sodium Glucose Cotransporter-2 Mitigates Heart Failure Progression in Obesity

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

The Effects of Sodium‐glucose Cotransporter 2 Inhibitors on Left Ventricular Function: Current Evidence and Future Directions

ESC heart failure
Cardiovascular MedicineCardiology
2019English

Sodium–Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Exploring Novel Pharmacotherapeutic Applications and Repurposing Potential of Sodium Glucose CoTransporter 2 (SGLT2) Inhibitors

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2018English

The Pleiotropic Effects of Sodium–Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy